Quantitative analysis of serum free light chains: A new marker for the diagnostic evaluation of primary systemic amyloidosis

American Journal of Clinical Pathology

Volumn 119, Issue 2, 2003, Pages 274-278

  Abraham, Roshini S ^a   Katzmann, Jerry A ^a   Clark, Raynell J ^a   Bradwell, A R ^a   Kyle, Robert A ^a,b   Gertz, Morie A ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

Amyloid; Amyloidosis; Immunoglobulins; Monoclonal gammopathy; Monoclonal light chains; Nephelometry; Stem cell transplantation

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; AMYLOID; BIOLOGICAL MARKER;

AMYLOIDOSIS; ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEPHELOMETRY; PLASMA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERODIAGNOSIS; STEM CELL TRANSPLANTATION; URINALYSIS; VALIDATION PROCESS; BLOOD; BONE MARROW; COMPARATIVE STUDY; IMMUNOASSAY; METABOLISM; METHODOLOGY; PATHOLOGY; PHOTOMETRY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AMYLOID; AMYLOIDOSIS; BIOLOGICAL MARKERS; BONE MARROW; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN LIGHT CHAINS; NEPHELOMETRY AND TURBIDIMETRY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION;

EID: 85047689163     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/LYWM47K2L8XYFFB3     Document Type: Article

References (18)

1. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am. 1999;13:1211-1233.
2. Rajkumar SV, Gertz MA, Kyle RA. Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer. 1998;82:1501-1505.
3. Perfetti V, Colli Vignarelli M, Anesi E, et al. The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients. Haematologica. 1999;84:218-221.
4. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45-59.
5. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997;336:1202-1207.
6. Comenzo RL, Vosburgh E, Falk RH, et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998;91:3662-3670.
7. Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem. 2001;47:673-680.
8. Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002;48:1437-1444.
9. Greipp PR, Witzig TE, Gonchoroff NJ. Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1). Am J Hematol. 1985;20:289-292.
10. Solomon A, Waldmann TA, Fahey JL, et al. Metabolism of Bence Jones proteins. J Clin Invest. 1964;43:103-117.
11. Durie BG, Persky B, Soehnlen BJ, et al. Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages. N Engl J Med. 1982;307:1689-1692.
12. Glenner GG. Alzheimer's disease: its proteins and genes. Cell. 1988;52:307-308.
13. Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 1988;52:487-501.
14. Tennent GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A. 1995;92:4299-4303.
15. Eriksson S, Janciauskiene S, Merlini G. The putative role of alpha-1-antitrypsin in the disaggregation of amyloid lambda fibrils. J Intern Med. 1995;237:143-149.
16. Gallo G, Wisniewski T, Choi-Miura NH, et al. Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol. 1994;145:526-530.
17. Abraham RS, Clark RJ, Bryant SC, et al. Correlation of serum immunoglobulin free light chain quantitation with urine Bence Jones protein in light chain myeloma. Clin Chem. 2002;48:655-657.
18. Drayson M, Tang LX, Drew R, et al. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood. 2001;97:2900-2902.